News
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...
Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.
For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days.
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...
5d
News-Medical.Net on MSNTirzepatide tops the charts for blood sugar and weight loss in type 2 diabetesA large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
5d
Best Life on MSNScientists Discover Another Major Weight-Loss Drug Side Effect—But This Time, It’s GoodResearchers say GLP-1 medicines might be able to help with migraines.
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results